Amneal Pharmaceuticals, Inc.AMRXNASDAQ
Loading
Year-over-year earnings per share growth rate
5Y CAGR
+83.3%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
20.7x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 1366.67% |
| Q3 2025 | -89.50% |
| Q2 2025 | 82.14% |
| Q1 2025 | 139.20% |
| Q4 2024 | -19900.00% |
| Q3 2024 | -102.58% |
| Q2 2024 | 106.47% |
| Q1 2024 | 25.00% |
| Q4 2023 | -766.67% |
| Q3 2023 | -25.00% |
| Q2 2023 | 220.48% |
| Q1 2023 | -71.58% |
| Q4 2022 | -144.94% |
| Q3 2022 | 98.02% |
| Q2 2022 | -1756.15% |
| Q1 2022 | -0.94% |
| Q4 2021 | -50.35% |
| Q3 2021 | -128.40% |
| Q2 2021 | 100.00% |
| Q1 2021 | 342.72% |
| Q4 2020 | 66.12% |
| Q3 2020 | 25.31% |
| Q2 2020 | -110.44% |
| Q1 2020 | 439.13% |
| Q4 2019 | 88.67% |
| Q3 2019 | -1461.54% |
| Q2 2019 | 64.86% |
| Q1 2019 | -437.01% |
| Q4 2018 | -237.80% |
| Q3 2018 | 102.89% |
| Q2 2018 | -484.44% |
| Q1 2018 | -16.67% |
| Q4 2017 | 134.78% |
| Q3 2017 | -30.30% |
| Q2 2017 | 17.86% |
| Q1 2017 | -3.45% |
| Q4 2016 | 0.00% |